Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
703
-
Total 13F shares, excl. options
-
94,533,097
-
Shares change
-
-2,110,016
-
Total reported value, excl. options
-
$24,611,319,237
-
Value change
-
-$550,619,558
-
Put/Call ratio
-
141%
-
Number of buys
-
292
-
Number of sells
-
-314
-
Price
-
$260.48
Significant Holders of RESMED INC - Common Stock (RMD) as of Q4 2021
791 filings reported holding RMD - RESMED INC - Common Stock as of Q4 2021.
RESMED INC - Common Stock (RMD) has 703 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94,533,097 shares
of 146,467,184 outstanding shares and own 64.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,613,249 shares), BlackRock Inc. (13,048,735 shares), WCM INVESTMENT MANAGEMENT, LLC (9,046,150 shares), STATE STREET CORP (6,523,922 shares), FMR LLC (4,689,025 shares), Capital World Investors (3,595,997 shares), GEODE CAPITAL MANAGEMENT, LLC (2,786,688 shares), NORTHERN TRUST CORP (2,242,075 shares), Invesco Ltd. (1,681,301 shares), and Ownership Capital B.V. (1,351,820 shares).
This table shows the top 703 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.